Search results

4bases is a company active in the fields of prevention and precision medicine. 4bases is a certified company working accordingly to the IVDR regulation. Our products are reagent kits for platform-independent New Generation DNA Sequencing (NGS), data analysis software and diagnostic protocols.

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.

BigOmics Analytics is a Swiss bioinformatics company accelerating omics data analysis for precision medicine. Its cloud-native platform, Omics Playground, empowers researchers to visualize, interpret and share complex omics data fostering efficient collaboration.

Bromatech has been engaged for more than 25 years in the study and development of targeted food supplements based on specific strains of lactic acid bacteria, antioxidants and essential fatty acids which are able to interact with the precious heritage of the human microbiota.

CROss Alliance® is a Swiss CRO specialised in early clinical development. With more than 500 trials performed at CROSS phase I unit or in selected EU sites, we are experts in PK, bioequivalence, first in man, tolerability studies including cardiac safety and efficacy models in healthy volunteers.

Devintec Pharma is focused on B2B partnerships through out-licensing innovative substance-based medical devices. We apply DevinPro™ technology, that addresses root causes and creates a protective barrier for lasting relief, to our patended products in gastroenterology, dermatology, and gynecology.

DIAMANTE is a boutique business and management consulting company dedicated to biotech/ pharma clients, diagnostics companies and investors in healthcare. We support companies to streamline product design and development, and work with investors to accelerate and de-risk their selected assets.

Ectica Technologies supplies hydrogel-based tools to the biopharmaceutical and life science industries for drug discovery and bioresearch applications. Ectica Technologies manufactures and supplies the 3DProSeed product line for drug discovery and research in oncology, immuno-oncology and neurosciences. It en

Clinical-stage biotech company developing next-generation allosteric therapies. Its candidate, GT-02287, is in P1b trials for PD with potential in other neurodegenerative and lysosomal storage disorders. The pipeline also includes preclinical programs targeting metabolic diseases and solid tumors.

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology and dermato-oncology.

InVirtuoLabs is pioneering the next-generation laboratory by integrating AI with molecular simulations to revolutionize drug discovery. Our platform generates up to 1 billion novel molecules per day, rapidly screening and identifying the most promising ligands for specific biological targets.

InkVivo Technologies combines its patented biomaterial platform with advanced manufacturing technologies to fabricate novel delivery systems that ensure controlled and prolonged release of active ingredients (e.g., small molecules, biologics and micronutrients).

Microsphere (MS) is a CDMO focused on new developments, cGMP manufacturing, R&D, analytical and regulatory support. MS is able to address complex challenges, including formulations for poorly water-soluble drugs, considering the extensive expertise in Spray Drying and Capsule Filling.

Streamlining complexity: with 15+ years experience (EU, US and Far East) in Oncology, Rare Diseases and Quality of Life Assessment, Naexture provides ad-interim leadership roles in Clinical Operations and Program Management to end-to-end operationalize clinical research programs.

Founded in 2018, Peptone specializes in novel therapeutics for Intrinsically Disordered Proteins (IDPs), linked to inflammatory diseases such as cancer. Their approach integrates biophysics, supercomputing, and machine learning, now advancing in their labs.

Sferalp is specialized in the formulation of Self Emulsifying Oils (SEFO) containing extracts or API. SEFO maximize gastro-intestinal absorption. We have developed a SEFO based on natural food components (Patent pending). We provide development in the field of electro- and conventional spray drying.

SPILLO supports pharmaceutical and biotech R&D teams through unbiased, in silico, proteome-wide identification of targets and off-targets. Using exclusive, experimentally validated, physics-based computational technology, SPILLO reduces scientific risk and clarifies mechanisms in drug development.